Repurposing Off-Patent Medicines: Insights from...

By HEOR Staff Writer

December 8, 2025

EU Pilot Initiative for Repurposing Off-Patent Medicines: Core Outcomes and Regulatory Support Repurposing off-patent medicines offers a p...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
C. auris Outbreak in Europe: Alarming Spread and Rising Resistance
CAPVAXIVE Pneumococcal Vaccine Delivers Strong Immune Response in At-Risk Youth
Ending Unproven Fertility Treatments: NICE Calls for Evidence-Based Care in C...
AMALFI Trial: How Patch-Based ECG Monitoring Could Transform Remote Atrial Fi...
FDA Guidance on Overall Survival Assessment in Oncology Trials
Guiding the Future of Digital Cardiac Rehabilitation: NICE’s Conditiona...
Unlocking Self-Care South Africa: Strategies and Challenges in Healthcare Reform
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...